BeStock  
Stocks › Biotechnology › TNGX

Tango Therapeutics TNGX

US equityMarket cap rank #2271Biotechnology
$21.73 −$0.98 (-4.32%)
Market closed · Nov 22, 5:30 am ET · Last extended-hours $22.00 +1.24%
Open$22.11
Prev close$22.71
Day range$21.63 – $23.05
Volume1.74M
Market cap$3.68B
P/E (TTM)–
Dividend yield–

TNGX Stock News

Headlines matching Tango Therapeutics or the TNGX ticker, most recent first.

  • Guggenheim Maintains Tango Therapeutics(TNGX.US) With Buy Rating, Maintains Target Price $35Market news · 24 Sep 2026 · Direct mention
  • CCORF Maintains Tango Therapeutics(TNGX.US) With Buy Rating, Maintains Target Price $46Market news · 24 Sep 2026 · Direct mention
  • H.C. Wainwright Maintains Tango Therapeutics(TNGX.US) With Buy Rating, Raises Target Price to $68 PositiveMarket news · 18 Aug 2026 · Direct mention
  • Stifel Maintains Tango Therapeutics(TNGX.US) With Buy Rating, Maintains Target Price $40Market news · 17 Aug 2026 · Direct mention
  • Guggenheim Maintains Tango Therapeutics(TNGX.US) With Buy Rating, Raises Target Price to $35 PositiveMarket news · 12 Aug 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Tango Therapeutics (TNGX), Maze Therapeutics, Inc. (MAZE) and Xtant Medical Holdings (XTNT)TipRanks · 12 Aug 2026 · Direct mention
  • Wedbush Maintains Tango Therapeutics(TNGX.US) With Buy Rating, Raises Target Price to $39 PositiveMarket news · 12 Aug 2026 · Direct mention
  • J.P. Morgan Initiates Tango Therapeutics(TNGX.US) With Buy Rating, Announces Target Price $46Market news · 15 Jul 2026 · Direct mention
  • A Quick Look at Today's Ratings for Tango Therapeutics(TNGX.US), With a Forecast Between $35 to $42Market news · 9 Jun 2026 · Direct mention
  • CCORF Maintains Tango Therapeutics(TNGX.US) With Buy Rating, Raises Target Price to $46 PositiveMarket news · 29 Jun 2026 · Direct mention
  • Jefferies Maintains Tango Therapeutics(TNGX.US) With Buy Rating, Maintains Target Price $60Market news · 26 Jun 2026 · Direct mention
  • Jefferies Upgrades Tango Therapeutics(TNGX.US) to Buy Rating, Raises Target Price to $60 PositiveMarket news · 26 Jun 2026 · Direct mention
  • CCORF Maintains Tango Therapeutics(TNGX.US) With Buy Rating, Maintains Target Price $42Market news · 11 Jun 2026 · Direct mention
  • H.C. Wainwright Maintains Tango Therapeutics(TNGX.US) With Buy Rating, Maintains Target Price $66Market news · 11 Jun 2026 · Direct mention
  • A Quick Look at Today's Ratings for Tango Therapeutics(TNGX.US), With a Forecast Between $32 to $66Market news · 10 Jun 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on TNGX.

Sign in to join the discussion.

Scroll to Top